Financials

Discussions Technicals Forecast Seasonals

UMED fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Unité de Fabrication de Médicaments is a holding company, which engages in the manufacture of pharmaceutical products. It offer generic drugs such as furoxem, bupicaine, mydricol, rachianestehesie,doperan, furoxem, levoject, ketomed, amoxil, ampicil, cefaxone, oflocol, and cefazol. The company was founded by Ridha Charfeddine in 1989 and is headquartered in Sousse, Tunisia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

UMED has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company